2-methyl-5,10-dihydro-4h-thieno[2,3-b][1,5]benzodiazepin-4-one

This compound is an active pharmaceutical ingredient impurity associated with the production of certain drugs. Its structure contains an amide and an amine group within a fused ring system, indicating it is a small-molecule impurity relevant to pharmaceutical manufacturing.